Figure 3.
Serum ATG5 (A) and P62 (B) before (T0) and 2 months (T2M) after mixture intake (n = 10) or no treatment (n = 10) in peripheral artery disease patients. Data are expressed as mean ± SD. * p < 0.05, ** p < 0.01.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.